Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis. Palazzo L, Clarelli F, Giordano A, Ferré L, Moiola L, Rocca MA, Esposito F, Filippi M, Clinical SanRaf MS Study Group J Neurol. 2026 Oct 05; 273(10). PMID: 42831942. Abstract CommentRecommendBookmarkWatch
